11332Lactate Dehydrogenase2
Albania medical device registration · Abbott Ireland Diagnostics Division, Lisnamuck, Longford, Co. Longford, Ireland · Invitro · Model Lactate Dehydrogenase2: 04T0320; 04T0330 · Registered February 24, 2022
- Risk Class
- Invitro
- Product Model
- Lactate Dehydrogenase2: 04T0320; 04T0330
- Product Name
- Lactate Dehydrogenase2
- Registration Date
- February 24, 2022
- Analysis ID
- 11332
Jane reagente qe perdoren per gjetjen sasiore te enzimes laktat dehidrogjenaze ne serumin dhe plazmen njerezore
Access comprehensive regulatory information for Lactate Dehydrogenase2 in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Abbott Ireland Diagnostics Division, Lisnamuck, Longford, Co. Longford, Ireland. The device was registered on February 24, 2022.
This page provides complete registration details including product model (Lactate Dehydrogenase2: 04T0320; 04T0330), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.